![]() ![]() Mol Cell Biol 23(4):1292–1303īuss NA, Henderson SJ, McFarlane M, Shenton JM, de Haan L (2012) Monoclonal antibody therapeutics: history and future. Curr Opin Cell Biol 23(4):464–475īrush MH, Weiser DC, Shenolikar S (2003) Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2. Cell 151(6):1163–1167īrodsky JL, Skach WR (2011) Protein folding and quality control in the endoplasmic reticulum: recent lessons from yeast and mammalian cell systems. Biotechnol Prog 21(1):106–111īrodsky JL (2012) Cleaning up: ER-associated degradation to the rescue. J Cell Biol 102(5):1558–1566īorth N, Mattanovich D, Kunert R, Katinger H (2005) Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line. Adv Drug Deliv Rev 58(5–6):671–685īole DG, Hendershot LM, Kearney JF (1986) Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J Biol Chem 254(13):5690–5694īhoskar P, Belongia B, Smith R, Yoon S, Carter T, Xu J (2013) Free light chain content in culture media reflects recombinant monoclonal antibody productivity and quality. Science 291(5503):447–507īergman LW, Kuehl WM (1979) Formation of intermolecular disulfide bonds on nascent immunoglobulin polypeptides. J Biotechnol 146(4):198–206īell AC, West AG, Felsenfeld G (2001) Insulators and boundaries: versatile regulatory elements in the eukaryotic genome. J Biotechnol 135(2):217–223īecker E, Florin L, Pfizenmaier K, Kaufmann H (2010) Evaluation of a combinatorial cell engineering approach to overcome apoptotic effects in XBP-1(s) expressing cells. J Proteome Res 11(11):5265–5276īecker E, Florin L, Pfizenmaier K, Kaufmann H (2008) An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processes. Curr Opin Biotechnol 17(4):381–386īaycin-Hizal D, Tabb DL, Chaerkady R, Chen L, Lewis NE, Nagarajan H, Sarkaria V, Kumar A, Wolozny D, Colao J, Jacobson E, Tian Y, O'Meally RN, Krag SS, Cole RN, Palsson BO, Zhang H, Betenbaugh M (2012) Proteomic analysis of Chinese hamster ovary cells. Biotechnol Bioeng 93(2):361–371īarnes LM, Dickson AJ (2006) Mammalian cell factories for efficient and stable protein expression. ![]() Biotechnol Bioeng 104(5):1041–1046īaik JY, Lee MS, An SR, Yoon SK, Joo EJ, Kim YH, Park HW, Lee GM (2006) Initial transcriptome and proteome analyses of low culture temperature-induced expression in CHO cells producing erythropoietin. EMBO J 29:3318–3329īahr SM, Borgschulte T, Kayser KJ, Lin N (2009) Using microarray technology to select housekeeping genes in Chinese hamster ovary cells. Int J Biochem Cell Biol 40(1):14–21Īppenzeller-Herzog C, Riemer J, Zito E, Chin KT, Ron D, Spiess M, Ellgaard L (2010) Disulfide production by Ero1α-PDI relay is rapid and effectively regulated. Proteomics 5(18):4689–4704Īmeri K, Harris AL (2008) Activating transcription factor 4. Nat Biotechnol 29(12):1083–1089Īlete DE, Racher AJ, Birch JR, Stansfield SH, James DC, Smales CM (2005) Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities. Here, this review describes the mechanism of antibody folding and assembly and recent advantages which could improve recombinant antibody production in mammalian cells by utilizing proteins such as ER chaperones or UPR-related proteins.Īggarwal S (2011) What's fueling the biotech engine-2010 to 2011. Accumulating studies by omics-based analysis of recombinant mammalian cells suggest that not only protein secretion processes including protein folding and assembly but also translation are likely to be the rate-limiting factors for increasing antibody production. The accumulation of unfolded proteins or intracellular antibody crystals accompanied by this failure triggers the unfolded protein response (UPR), which can considerably attenuate the levels of translation, folding, assembly, and secretion, resulting in reduction of antibody productivity. If these reactions do not proceed appropriately, unfolded or misfolded proteins are degraded by the ER-associated degradation (ERAD) pathway. Nascent polypeptides must be subjected to protein folding and assembly in the ER and the Golgi to be secreted as mature proteins. Mammalian cells have been successfully used for the industrial manufacture of antibodies due to their ability to synthesize antibodies correctly. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |